Sun Pharmaceutical has received the US Food and Drug Administration (FDA) acceptance for its manufacturing plant at Cranbury in New Jersey, US.
Earlier, the company has received a warning letter from the agency on 25 August 2010 for violating good manufacturing practice regulations. The issuance of the letter follows FDA inspection of the site.
Caraco, now wholly owned by Sun Pharma, continues to work with consultants to resolve the issues raised by the FDA at its Detroit plant.
